Navigation Links
Vioxx's Heart Risk Lingered Long After Use Ended
Date:10/13/2008

ed that the risk for heart attack and stroke continued even after Vioxx was stopped.

"What this does is help further demonstrate not only the risk of Vioxx, but the temporal duration," Topol said. "Now, we have compelling data that the risk extends a year after stopping the drug," he said.

Topol, who was one of the first to sound the alarm about Vioxx, is not sure that this is a class effect of all cox-2 inhibitors, however.

"There was always a signal that it [the risk] was worse for Vioxx that other cox-2 inhibitors. Whether or not other drugs like Celebrex shared that isn't known. That has not been demonstrated in studies of Celebrex. But you have to be suspicious, particularly since high doses of Celebrex have heart attack and stroke risk. But there's never been a study to show that it's a long-lasting liability," he said.

More information

For more about pain relievers, visit the U.S. National Library of Medicine.



SOURCES: Robert Bresalier, M.D., professor, medicine, M.D. Anderson Cancer Center, University of Texas, Houston; Eric J. Topol, M.D., director, Scripps Translational Science Institute, Chief Academic Officer, Scripps Health, La Jolla, Calif; Oct. 13, 2008, online edition, The Lancet


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Hospital-based smoking cessation program after heart attack adds to success
2. Little-Known Fat Can Be a Heartbreaker
3. Blood Cell Genes May Signal Heart Disease
4. Touchstone Health Partners with the American Heart Association and American Stroke Association to Fight Cardiovascular Disease Among Seniors
5. Florida study finds barriers to angioplasty for life-threatening heart attacks
6. Northwestern Memorial trials implantable device to manage congestive heart failure symptoms
7. "PEACE of Heart" Campaign Comes to Metro Washington to Help Fight Heart Disease Epidemic among Minorities : Hallmark of Campaign's Health Screening Events Is Personalized Follow-Up
8. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
9. American Heart Association Announces Start! Fit-Friendly Companies
10. American Heart Association Calls on Presidential Candidates to Adopt the Organizations New Principles on Healthcare Reform
11. Heart CT Scan Helps Find Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vioxx's Heart Risk Lingered Long After Use Ended
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
(Date:1/22/2015)... Orlando, Florida (PRWEB) January 22, 2015 ... up today at the 2015 PGA Merchandise Show to ... lady and incredible female amateur golfer, Arlene McKitrick. The ... career female amateur golf tournament win. She won her ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... HealthDay Reporter , TUESDAY, Dec. 14 (HealthDay ... years, especially women, are less likely to face the ... researchers say. But regular exercise while young only ... about 150 minutes of moderate to vigorous physical activity ...
... vaccines targeted against various types of cancer has raised ... however, is that these promising treatments are difficult to ... cellular target to stop cancer growth without inactivating the ... report a laboratory finding that has the potential to ...
... 14, 2010 Researchers at UT Southwestern Medical Center ... and normal tissue that predict survival time and potential ... "Patient responses to cancer treatment vary widely and ... Dr. David Mangelsdorf, chairman of pharmacology at UT Southwestern ...
... weapon against inoperable liver cancer is so tiny that ... to interventional radiologists at the Indiana University School of ... The glass spheres contain a radioactive element, yttrium-90, ... a very limited distance so that healthy tissue around ...
... Pallarito HealthDay Reporter , TUESDAY, Dec. 14 (HealthDay ... a key component of the new U.S. health-care reform law ... the first successful challenge to the controversial legislation. ... President Barack Obama and fellow Democrats against Republicans, will continue ...
... -- Scientists report that they have advanced their knowledge ... identifying 13 new potential variations. Tumors called pheochromocytomas ... the kidney. These tumors -- which are usually benign ... gland to produce too much adrenaline, resulting in high ...
Cached Medicine News:Health News:Regular Exercise While Young May Slow Middle-Age Spread 2Health News:Regular Exercise While Young May Slow Middle-Age Spread 3Health News:UNC scientists discover potential strategy to improve cancer vaccines 2Health News:Gene information predicts survival time, possible new treatment options for lung-cancer patients 2Health News:Y-90 radioembolization offers promise for late-stage liver cancer 2Health News:Health-Care Reform Faces Long Legal Fight 2Health News:Health-Care Reform Faces Long Legal Fight 3Health News:Health-Care Reform Faces Long Legal Fight 4
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/23/2015)... Jan. 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the development and sale of patented biopharmaceutical medicine, ... pharmaceutical ingredients (API) today announced the business and development ... 1. Following the September 2014 JCM application ...
(Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... EXTON, Pa., Aug. 18, 2011 Kensey Nash Corporation (NASDAQ: ... on regenerative medicine for a wide range of medical procedures, ... year ended June 30, 2011.   Fourth ... earnings per share of $0.34, which includes net Norian acquisition ...
... MEDFORD, N.Y., Aug. 18, 2011 Richard Larkin, Chief Financial ... develops, manufactures, markets and licenses point-of-care diagnostic tests, is among ... from Long Island Business News ( LIBN ). ... year.  Among the honorees, Mr. Larkin was one of two ...
Cached Medicine Technology:Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 14Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 15Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 16Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 17Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 18Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 19Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 20Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 21Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News 2Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News 3
... Eliminate the need for makeshift, modified nebulizer ... waste time gathering parts when your patient ... to deliver the utmost in Heliox rescue ... is fast becoming the standard of care ...
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... as well as humidification, try Flo-Mist™., ... volume, continuous medication nebulizer (CMN), engineered to ... 200 ml reservoir and jet flow design ... nebulized medication delivery at 25 ml/hr. Particles ...
Medicine Products: